Rémi Patouret

Randomised, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I Study of QGC001, a Centrally Acting Aminopeptidase A Inhibitor Prodrug

Fabrice Balavoine, Michel Azizi, Damien Bergerot et al. · Clinical Pharmacokinetics · 2013 · 56 citations

Biochemistry, Medicine, Pharmacotherapy +6

<i>N</i>‐Arylsulfonyl Indolines as Retinoic Acid Receptor‐Related Orphan Receptor γ (RORγ) Agonists

Christelle Doebelin, Rémi Patouret, Rubén D. Garcia-Ordoñez et al. · ChemMedChem · 2016 · 38 citations · Full text

HDX-MS reveals structural determinants for RORγ hyperactivation by synthetic agonists

Timothy S. Strutzenberg, Rubén D. Garcia-Ordoñez, Scott J. Novick et al. · eLife · 2019 · 29 citations · Full text

Specific Cognate Ligands, Molecular Regulation, Cancer Biology +18

Synthesis of 2-aryl-2H-tetrazoles via a regioselective [3+2] cycloaddition reaction

Rémi Patouret, Theodore M. Kamenecka · Tetrahedron Letters · 2016 · 28 citations · Full text

Organic Chemistry, Heterocyclic, Chemistry

Identification of a Covalent Importin-5 Inhibitor, Goyazensolide, from a Collective Synthesis of Furanoheliangolides

Weilong Liu, Rémi Patouret, Sofía Barluenga et al. · ACS Central Science · 2021 · 22 citations · Full text

Combinatorial Chemistry, Covalent Importin-5 Inhibitor, Covalent Inhibitors +18